Listen Now

Ian Bolland is joined by Ashleigh Batchen, Regulatory Affairs Manager from the British In Vitro Diagnostics Association (BIVDA) to discuss the MHRA's published consultation about how medical devices and IVDs will be regulated in the UK post-Brexit. They also touch upon experiences that can be learnt from the implementation of EU MDR and IVDR when transitioning to a new regulation and potential challenges along the way for manufacturers, and when it comes to notified body capacity. You can read the consultation here: https://www.med-technews.com/news/Medtech-Regulatory-News/industry-reacts-to-consultation-on-uk-medical-device-regulat/ This podcast is sponsored by Arena, a PTC Company, for more information visit: https://www.ptc.com/en/products/arena

Ian Bolland is joined on the MedTalk Podcast by Markus Fleckenstein from this episode’s sponsor Arena, a PTC business. The pair discuss the importance of quality management systems for medical device manufacturers, the essential nature of regulatory compliance, design controls, requirements management and documents management – and how these can be resolved with a good quality management system. Learn more about Arena at: https://www.ptc.com/en/products/arena

Ian Bolland is joined by Arnaub Chatterjee, Senior Vice President - Acorn AI at Medidata to discuss how artificial intelligence is increasingly being used in clinical trials, and its potential benefits. The podcast also contains a sponsorship segment from Wilmington Healthcare.

Ian Bolland is joined by Oli Hudson, content director of Wilmington Healthcare, to discuss the procurement challenges medtech companies face, explaining why medtech firms face a 'new NHS' and comments on the state of the nation report recently release by the company. You can read the State of the Nation report by Wilmington Healthcare at: https://wilmingtonhealthcare.com/state-of-the-nation/ This podcast is sponsored by Wilmington Healthcare. For more information, visit: https://wilmingtonhealthcare.com

In the latest episode in the Meet the Speaker series ahead of Med-Tech Innovation Expo, Ian Bolland is joined by Dan Clark from CHEATA, a clinical engineer of over 30 years in the NHS.While looking ahead to his seminar on Day One. The duo talk about the progress made when it comes to NHS technological adoption, and in areas where the NHS has become more savvy, and whether there is a change in approach when it comes to adopting new technologies within the health service in light of the pandemic. Dan Clark will feature on the Med-Tech Innovation Conference Stage in association with Medilink at 12pm on Wednesday 8th June. You can register at www.med-techexpo.com.

Ian Bolland is joined by Joe Rowan, president and CEO of Junkosha, who introduces Chris Hancock from Creo Medical as the winner of Junkosha’s Technology Innovator Award. The trio talk about this year’s winning innovation, where the idea came from, the effects the prize can have on Creo, and what Junkosha might be looking for from its next round of entrants. You can listen to the episode about the awards being launched here: https://soundcloud.com/medtalkpodcast/search-for-life-sciences-innovators This episode of The MedTalk Podcast is brought to you by Wilmington Healthcare... for more information visit: https://wilmingtonhealthcare.com

As part of our meet the speaker series ahead of Med-Tech Innovation Expo, Ian Bolland talks to our keynote speaker for day 2 on the Med-Tech Innovation Conference stage. Karen Taylor is director of the Deloitte Centre for Health Solutions and she will be presenting the findings of research into diagnostic innovation and the future of diagnostics. Karen covers what the research has covered ahead of its publication and discusses what changes we might need to see ahead of more widespread adoption. You can hear more from Karen on Day 2 of the Med-Tech Innovation Expo on the Med-Tech Innovation Conference Stage in association with Medilink UK at 10:30. Register for Med-Tech Innovation Expo at www.med-techexpo.com

In the second episode of our Meet the Speaker series, Ian Bolland is joined by Helena Zaum, social care lead for Microsoft as they talk about the need to embrace technology in the social care sector, how it differs from the NHS, as well as a look ahead to Helena’s seminar: creating innovative ecosystems for effective social care. Please note this talk has been moved to 12pm rather than 12:30 as previously advertised. You can register for the Med-Tech Innovation Expo at med-techexpo.com. https://med-techexpo.com/?utm_source=MTINews&utm_medium=Hyperlink&utm_campaign=MTINewsWebsite

In the first of our Meet the Speaker series ahead of Med-Tech Innovation Expo, Ian Bolland is joined by Ashley Sayed whose seminar focuses on Manufacturing 5.0 and how that can apply in the healthcare sector. The duo discuss how Ashley arrived at where he is today, and what the audience on Day One can expect from his talk, including the main differences from Industry 4.0 and 5.0. You can join Ashley’s seminar on Day One at 12.30pm on the Med-Tech Innovation Conference organised with Medilink UK. Register for Med-Tech Innovation Expo at www.med-techexpo.com

Ian Bolland is joined by Jonathan O’Halloran, chief executive officer of QuantuMDx, to discuss the uses of PCR testing (aside from COVID), its latest technology, the difference between point of need and point of care testing, the UK government policy on diagnostics and where the industry stands in light of the pandemic. QuantuMDx recently published a report on point of need testing, which you can read here: https://www.med-technews.com/news/Medtech-Diagnostics-news/quantumdx-explores-future-of-point-of-need-pcr-testing/

European Pharmaceutical Manufacturer editor Reece Armstrong speaks to Matt Farrar, founder of digital consultancy LovedBy about the problems facing clinical trials in terms of patient engagement. The duo discusses challenges of trial design, interoperability throughout the NHS and how trials can be better suited to patients.

In this episode, Reece Armstrong, editor of European Pharmaceutical Manufacturer speaks to Mike Rea CEO and founder of IDEA Pharma & Protodigm. Mike is an expert in all things drug development and through his companies has played a role in helping position 8 of the 15 biggest drug launches of the last five years. Here we talk about the challenges of drug development and discovery, upcoming technologies and his time spent in the industry.

Ian Bolland, acting group editor of Med-Tech Innovation and Medical Plastics News, is joined by Dr Simon Wallace, chief clinical information officer at Nuance Communications. The pair discuss the administrative burden on clinical staff, including the effects of the pandemic, and how voice recognition technology could be a tool to help both patients and clinicians as the health service tackles record waiting times. This podcast is sponsored by Wilmington Healthcare. For more information, please visit www.wilmingtonhealthcare.com.

Ian Bolland is joined by Martin Gouldstone and Ray Valencia from Sensyne Health to explain more about the use of synthetic control arms, clinical trial transformation, speeding up the process and its SENSIGHT platform – which works within the NHS. This is brought to you by the Med-Tech Innovation Awards – for more information, and to submit your entry, visit med-techawards.com.

In this episode, we speak to professor Janet Hemingway, the founding director of the Infection Innovation Consortium (iiCON). Professor Hemingway discusses the work iiCON has done throughout the Covid-19 pandemic, how it is helping SMEs connect with pharma companies, and its plans on tackling antibiotic resistance and more.

Corrine Lawrence and Caroline Jackson from Medical Plastics News are joined by Arjun Luthra, commercial director of Biointeractionsto discuss its infection prevention technology and its efforts to be adopted by the UK government.

On the anniversary of the company receiving NICE approval for its ZIO XT medical device, Ian Bolland is joined by Glyn Barnes, director of strategic marketing at iRhythm to discuss going through the approvals process, advice for companies ahead of any application and the effect receiving NICE approval has had on the company during the last 12 months. This podcast is sponsored by Wilmington Healthcare, visit www.wilmingtonhealthcare.comfor more information.

Med-Tech Innovation editor Ian Bolland is joined by Phil Groom, commercial director (global) at Bond Digital Health. They discuss the change when it comes to awareness of lateral flow diagnostics, the future of lateral flow and how data can help mitigate future pandemics. The duo refer to a piece previously written by Phil, which you can read here: https://medcitynews.com/2021/09/we-can-prevent-the-next-pandemic-with-data

In this episode we speak to Professor David Nutt about his recent decision to join the biotech Awakn Life Sciences to help the company bring about a change to mental health treatments through the use of psychedelic medicines.

Ian Bolland and Reece Armstrong are back in the same room, this time discussing the government's latest report on lessons learned during the coronavirus pandemic. The duo also discuss the latest Covid-19 innovations within medtech and news on how wealthy countries aren't doing their bit to support poorer nations during the pandemic. You can read the report mentioned in the episode here: https://committees.parliament.uk/work/657/coronavirus-lessons-learnt/news/157991/coronavirus-lessons-learned-to-date-report-published/